Agios Pharmaceuticals
AGIO
#5180
Rank
NZ$2.86 B
Marketcap
NZ$48.09
Share price
-2.26%
Change (1 day)
-2.62%
Change (1 year)

Market capitalization of Agios Pharmaceuticals (AGIO)

Market cap: NZ$2.86 Billion

As of May 2026 Agios Pharmaceuticals has a market cap of NZ$2.86 Billion. This makes Agios Pharmaceuticals the world's 5180th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Agios Pharmaceuticals from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$2.86 B1.37%
2025NZ$2.82 B-16.47%
2024NZ$3.37 B71.6%
2023NZ$1.96 B-19.01%
2022NZ$2.43 B-7.02%
2021NZ$2.61 B-37.16%
2020NZ$4.15 B-14.24%
2019NZ$4.84 B21.18%
2018NZ$4.00 B1.97%
2017NZ$3.92 B55.06%
2016NZ$2.53 B-29.21%
2015NZ$3.57 B-32.6%
2014NZ$5.30 B483.39%
2013NZ$0.90 B

End of Day market cap according to different sources

On May 22nd, 2026 the market cap of Agios Pharmaceuticals was reported to be:

NZ$2.86 Billion
by Nasdaq info icon info icon
NZ$2.86 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
NZ$252.27 B 8,720.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$1.623 T 56,648.55%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$176.20 B 6,060.83%๐Ÿ‡ฌ๐Ÿ‡ง UK
Xencor
XNCR
NZ$1.43 B-49.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
NZ$21.54 B 653.23%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$17.86 B 524.71%๐Ÿ‡บ๐Ÿ‡ธ USA